The purpose of this report is (1) to summarize the clinical evidence supporting the intradermal route for vaccine administration and the devices being developed for this purpose; (2) to determine whether intradermal delivery broadly holds promise for vaccine applications for low- and middle-income countries in the future; and (3) to begin to prioritize vaccine targets and device strategies that best fit the public health needs in these countries and likely merit further investigation. The document is available as one large file or as four smaller files for easier downloading.

Corporate author(s): PATH

Published: August 2009

Region: Global